Gaudium IVF and Women Health Limited’s Initial Public Offer of Equity Shares to open on February 20, 2026
FinTech BizNews Service
Mumbai, 17 February 2026: Gaudium IVF and Women Health Limited (“Gaudium IVF” or “The Company”), announces that the Bid / Offer Opening Date in relation to its initial public offer of the Equity Shares (“Offer”) will be Friday, February 20, 2026.
(Left To Right): Mr. Viren Kanojia, Senior Analyst, Sarthi Capital Advisors Private Limited; Mr. Vishad Khanna, Non- Executive Director, Gaudium IVF And Women Health Limited; Dr. Manika Khanna, Chairperson & Managing Director, Gaudium IVF And Women Health Limited; And Mr. Rakesh Kumar Sharma, Chief Financial Officer, Gaudium IVF And Women Health Limited
The Offer comprises a fresh issue of such number of Equity Shares by the Company aggregating up to 1,13,92,500 Equity Shares (the “Fresh Issue”) and an offer for sale of up to 94,93,700 Equity Shares (the “Offer for Sale”) by Dr. Manika Khanna, promoter selling shareholder (the “Selling Shareholder”).
The Company proposes to utilise the Net Proceeds towards Funding capital expenditure towards establishment of New IVF Centers of the Company, Repayment/pre-payment, in full or in part, of certain outstanding loans availed by the Company, and general corporate purposes (the “Objects of the Offer”).
The Anchor Investor Bid/Offer Period opens and closes on Wednesday, February 18, 2026. The Bid/Offer Period will open on Friday, February 20, 2026 for subscription and close on Tuesday, February 24, 2026.
The Price Band of the Offer has been fixed at Rs75 to Rs79 per Equity Share. Bids can be made for a minimum of 189 Equity Shares and in multiples of 189 Equity Shares thereafter.
This Equity Shares are being offered through the RHP.
The Equity Shares to be offered through the RHP are proposed to be listed on the Main Board of BSE Limited and National Stock Exchange of India Limited (“NSE”). For the purposes of the Offer, NSE is the Designated Stock Exchange.
Sarthi Capital Advisors Private Limited is the sole Book Running Lead Manager to the Offer (the “BRLM”).
